Cyclophosphamide inhibition of insulin antibody production, insulin resistance and experimental immunodiabetes.
D000818:Animals; D000917:Antibody Formation / Q000187:drug effects; D001786:Blood Glucose; D003520:Cyclophosphamide / Q000494:pharmacology*; D003921:Diabetes Mellitus, Experimental / Q000097:blood / Q000276:immunology*; D006168:Guinea Pigs; D007165:Immunosuppression Therapy; D007330:Insulin Antibodies / Q000096:biosynthesis*; D007333:Insulin Resistance / Q000187:drug effects*; D007515:Islets of Langerhans / Q000276:immunology / Q000473:pathology; D008854:Microscopy, Electron; D011234:Precipitins / Q000096:biosynthesis
D001786:Blood Glucose; D007330:Insulin Antibodies; D011234:Precipitins; D003520:Cyclophosphamide